Home › Kanser sa Atay (Hepatocellular Carcinoma) › Texas › Dallas
Pag-aaral pangklinika para sa Kanser sa Atay (Hepatocellular Carcinoma) sa Dallas, TX
19 pag-aaral para sa Kanser sa Atay (Hepatocellular Carcinoma) ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Dallas (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
Nagre-recruitPhase 1
- Exelixis Clinical Site #89, Dallas
National Liver Cancer Screening Trial
Nagre-recruitPhase 4
- UT Southwestern Medical Center and Parkland Hospital, Dallas
GPC3-Targeted T-Cell Therapy (ECT204) in Adults With Advanced HCC
Nagre-recruitPhase 1/2
- University of Texas Southwestern, Harold C. Simmons Comprehensive Cancer Center, Dallas
THIO and Cadonilimab in Resectable Hepatocellular Carcinoma
Nagre-recruitMaagang Phase 1
- University of Texas Southwestern Medical Center, Dallas
Adaptive Dosing of Immune Checkpoint Inhibitors for Hepatocellular Carcinoma
Nagre-recruitPhase 2
- University of Texas Southwestern Medical Center, Dallas
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
Nagre-recruitPhase 1/2
- Texas Oncology, P.A., Dallas
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
Nagre-recruitPhase 2
- Baylor Scott & White Research Institute, Dallas
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
Nagre-recruitPhase 1
- University of Texas Southwestern Medical Center - Simmons Cancer Center, Dallas
- UT Southwestern Medical Center - Redbird, Dallas
- Univ. of TX Southwestern Medical Center - Zale Lipshy University Hospital, Dallas
- at 2 pa
CEUS vs. AMRI for HCC Detection in Patients With Indeterminate Liver Nodules
Nagre-recruit
- University of Texas Southwestern Medical Center, Dallas
A Study to Evaluate ALN-BCAT in Patients With Hepatocellular Carcinoma
Nagre-recruitPhase 1
- Clinical Trial Site, Dallas
Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI
Nagre-recruit
- VA North Texas Health Care System Dallas VA Medical Center, Dallas, TX, Dallas
A Study of TTI-101 as Monotherapy and in Combination in Participants With Locally Advanced or Metastatic, and Unresectable Hepatocellular Carcinoma
Nagre-recruitPhase 1/2
- Harold C. Simmons Comprehensive Cancer Center, Dallas
Evaluation of Resection Techniques for Pancreatic Tumors
Nagre-recruitObservasyonal na pag-aaral
- Methodist Dallas Medical Center, Dallas
Ligufalimab and Cadonilimab in Advanced Liver Cancers
Nagre-recruitPhase 2
- University of Texas Southwestern Medical Center, Dallas
Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years
Nagre-recruitPhase 4
- UT Southwestern Medical Center, Dallas
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
Nagre-recruitPhase 1/2
- Research Site 120, Dallas
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Nagre-recruitObservasyonal na pag-aaral
- Massive Bio SYNERGY-AI site, Dallas
EGCG for Hepatocellular Carcinoma Chemoprevention
Nagre-recruitPhase 2
- UT Southwestern, Dallas
Namodenoson in the Treatment of Advanced Hepatocellular Carcinoma in Patients With Child-Pugh Class B7 Cirrhosis
Nagre-recruitPhase 3
- Site 881, Dallas
Pag-aaral para sa Kanser sa Atay (Hepatocellular Carcinoma) sa ibang lungsod
- Houston, TX31 pag-aaral
- New York City, NY24 pag-aaral
- Los Angeles, CA19 pag-aaral
- Boston, MA18 pag-aaral
- Cleveland, OH18 pag-aaral
- Philadelphia, PA16 pag-aaral
- Chicago, IL16 pag-aaral
- Pittsburgh, PA15 pag-aaral
- San Francisco, CA14 pag-aaral
- Orange, CA14 pag-aaral
- Jacksonville, FL14 pag-aaral
- San Antonio, TX13 pag-aaral
Iba pang pag-aaral sa Dallas
- Kanser sa Suso55 pag-aaral
- Non-Small Cell Lung Cancer52 pag-aaral
- Metastatic Cancer42 pag-aaral
- Pagkabigo ng Puso42 pag-aaral
- Kanser (lahat ng uri)37 pag-aaral
- Kanser sa Prostate36 pag-aaral
- Colorectal Cancer33 pag-aaral
- Obesity30 pag-aaral
- Kanser sa Ovary28 pag-aaral
- Kanser sa Baga27 pag-aaral
- Kanser sa Pantog27 pag-aaral
- Kanser ng Endometrium24 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.